Found: 35
Select item for more details and to access through your institution.
A Drug‐Drug Interaction Study Evaluating the Effect of Givosiran, a Small Interfering Ribonucleic Acid, on Cytochrome P450 Activity in the Liver.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1250, doi. 10.1002/cpt.2419
- By:
- Publication type:
- Article
Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug Reactions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1311, doi. 10.1002/cpt.2411
- By:
- Publication type:
- Article
Model‐Informed Drug Development: Connecting the Dots With a Totality of Evidence Mindset to Advance Therapeutics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1147, doi. 10.1002/cpt.2422
- By:
- Publication type:
- Article
Population Pharmacokinetics and Pharmacodynamics of the Neutralizing Antibodies Bamlanivimab and Etesevimab in Patients With Mild to Moderate COVID‐19 Infection.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1302, doi. 10.1002/cpt.2420
- By:
- Publication type:
- Article
Exposure–Response Analyses for Therapeutic Dose Selection of Belantamab Mafodotin in Patients With Relapsed/Refractory Multiple Myeloma.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1282, doi. 10.1002/cpt.2409
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1145, doi. 10.1002/cpt.2421
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1157, doi. 10.1002/cpt.2417
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1155, doi. 10.1002/cpt.2418
- Publication type:
- Article
Impact of SARS‐CoV‐2 Infection (COVID‐19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1358, doi. 10.1002/cpt.2412
- By:
- Publication type:
- Article
Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1368, doi. 10.1002/cpt.2408
- By:
- Publication type:
- Article
A Model‐Based Workflow to Benchmark the Clinical Cholestasis Risk of Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1293, doi. 10.1002/cpt.2406
- By:
- Publication type:
- Article
Quantitative Proteomic Map of Enzymes and Transporters in the Human Kidney: Stepping Closer to Mechanistic Kidney Models to Define Local Kinetics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1389, doi. 10.1002/cpt.2396
- By:
- Publication type:
- Article
Corrigendum: Developing and Validating a Clinical Warfarin Dose‐Initiation Model for Black‐African Patients in South Africa and Uganda.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1402, doi. 10.1002/cpt.2395
- Publication type:
- Article
Investigation of Factors Associated With Immunogenicity Labeling Updates and Characteristics of Biologics License Applications.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1381, doi. 10.1002/cpt.2393
- By:
- Publication type:
- Article
Hypothalamic‐Pituitary‐Adrenal Activity in Adverse Events Reporting After Placebo Administration.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1349, doi. 10.1002/cpt.2388
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of High‐Volume Subcutaneous Crenezumab, With and Without Recombinant Human Hyaluronidase in Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1337, doi. 10.1002/cpt.2385
- By:
- Publication type:
- Article
Metformin Stimulates Intestinal Glycolysis and Lactate Release: A single‐Dose Study of Metformin in Patients With Intrahepatic Portosystemic Stent.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1329, doi. 10.1002/cpt.2382
- By:
- Publication type:
- Article
Current and Next Steps Toward Prediction of Human Dose for Gene Therapy Using Translational Dose‐Response Studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1176, doi. 10.1002/cpt.2374
- By:
- Publication type:
- Article
Optimized Alectinib Dose Regimen for Treatment of Patients With ALK‐Positive Non‐Small Cell Lung Cancer Based on Robust Pharmacometric Analyses and Clinical Evidence.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1162, doi. 10.1002/cpt.2373
- By:
- Publication type:
- Article
Response to "Optimized Alectinib Dose Regimen for Treatment of Patients With ALK‐Positive NSCLC Based on Robust Pharmacometric Analyses and Clinical Evidence".
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1164, doi. 10.1002/cpt.2372
- By:
- Publication type:
- Article
The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1318, doi. 10.1002/cpt.2366
- By:
- Publication type:
- Article
Erratum: A Model Averaging/Selection Approach Improves the Predictive Performance of Model‐Informed Precision Dosing: Vancomycin as a Case Study.
- Published in:
- 2021
- Publication type:
- Correction Notice
A Model‐Based Approach to Assess Unstable Creatinine Clearance in Critically Ill Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1240, doi. 10.1002/cpt.2341
- By:
- Publication type:
- Article
Quantitative Clinical Pharmacology Supports the Bridging From i.v. Dosing and Approval of s.c. Rituximab in B‐Cell Hematological Malignancies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1261, doi. 10.1002/cpt.2308
- By:
- Publication type:
- Article
Model‐Informed Therapeutic Dose Optimization Strategies for Antibody–Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration–Approved Antibody–Drug Conjugates?
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1216, doi. 10.1002/cpt.2278
- By:
- Publication type:
- Article
Lorlatinib Exposure‐Response Analyses for Safety and Efficacy in a Phase I/II Trial to Support Benefit–Risk Assessment in Non‐Small Cell Lung Cancer.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1273, doi. 10.1002/cpt.2228
- By:
- Publication type:
- Article
Physiologically‐Based Pharmacokinetic Modeling to Support the Clinical Management of Drug–Drug Interactions With Bictegravir.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1231, doi. 10.1002/cpt.2221
- By:
- Publication type:
- Article
Moving From Point‐Based Analysis to Systems‐Based Modeling: Integration of Knowledge to Address Antimicrobial Resistance Against MDR Bacteria.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1196, doi. 10.1002/cpt.2219
- By:
- Publication type:
- Article
Industrial Perspective on the Benefits Realized From the FDA's Model‐Informed Drug Development Paired Meeting Pilot Program.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1172, doi. 10.1002/cpt.2265
- By:
- Publication type:
- Article
Public Workshop Summary Report on Fiscal Year 2021 Generic Drug Regulatory Science Initiatives: Data Analysis and Model‐Based Bioequivalence.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1190, doi. 10.1002/cpt.2120
- By:
- Publication type:
- Article
An Integrated Approach for Assessing the Impact of Renal Impairment on Pharmacokinetics of Drugs in Development: Pivotal Role of PBPK Modelling.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1168, doi. 10.1002/cpt.2243
- By:
- Publication type:
- Article
Clinical Design and Analysis Strategies for the Development of Gene Therapies: Considerations for Quantitative Drug Development in the Age of Genetic Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1207, doi. 10.1002/cpt.2224
- By:
- Publication type:
- Article
Model Informed Drug Development: Collaboration Through A Common Framework.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1165, doi. 10.1002/cpt.2066
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1137, doi. 10.1002/cpt.1905
- Publication type:
- Article
The Evidence REVEAL Study: Exploring the Use of Real‐World Evidence and Complex Clinical Trial Design by the European Pharmaceutical Industry.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1180, doi. 10.1002/cpt.2103
- By:
- Publication type:
- Article